Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 SEK | -96.26% | -.--% | -22.82% |
04-29 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
04-29 | Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina | CI |
Performance
1 day | -4.63% | ||
3 months | -27.79% | ||
6 months | +41.56% | ||
Current year | -22.82% | ||
1 year | -60.00% | ||
3 years | -98.73% | ||
5 years | -99.27% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Medical Diagnostic & Testing Equipment
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-96.26% | -.--% | -22.82% | -60.00% | 6.9M | ||
-1.17% | -2.99% | -42.86% | -51.78% | 2.85B | ||
-1.24% | -2.83% | +20.51% | +89.78% | 1.94B | ||
-1.51% | -8.97% | -1.13% | +31.20% | 1.68B | ||
-0.12% | +0.30% | +27.00% | +20.85% | 1.26B | ||
-3.77% | -6.87% | -14.07% | -17.00% | 1.03B | ||
-2.85% | -2.44% | -20.60% | -34.00% | 938M | ||
+0.22% | +1.93% | +0.88% | -21.26% | 783M | ||
+0.98% | -0.77% | -24.34% | -30.17% | 628M | ||
-5.14% | +1.54% | +8.73% | +27.91% | 535M | ||
+2.65% | -.--% | -.--% | -.--% | 481M | ||
+3.05% | +5.76% | -19.37% | +43.49% | 257M | ||
+15.09% | +16.73% | -41.53% | -12.30% | 197M | ||
-2.87% | -6.57% | +13.17% | +196.24% | 129M | ||
-1.99% | +2.54% | -30.03% | -26.19% | 108M | ||
+2.08% | +43.62% | +128.81% | +90.14% | 86.72M | ||
Average | -0.08% | +2.27% | -1.10% | +15.43% | ||
Weighted average by Cap. | -0.96% | -2.32% | -7.60% | +5.68% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -22.82% | ||
2023 | -93.12% | ||
2022 | -63.26% | ||
2021 | -40.70% | ||
2020 | -32.17% | ||
2019 | -6.79% | ||
2018 | +96.31% |
- Stock Market
- Equities
- IMMNOV Stock
- 0G8X Stock
- Quotes Immunovia AB